News
WST
269.81
+1.24%
3.31
Parnassus Mid Cap Growth Fund Q1 2026 Portfolio Activity
Seeking Alpha · 20h ago
West Pharma Is Maintained at Equal-Weight by Barclays
Dow Jones · 2d ago
West Pharma Price Target Raised to $275.00/Share From $265.00 by Barclays
Dow Jones · 2d ago
Barclays Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $275
Benzinga · 2d ago
Will West Pharmaceutical’s New Dublin Automation Hub for High-Volume Injectables Change West’s (WST) Narrative?
Simply Wall St · 2d ago
West Pharmaceutical price target raised to $275 from $265 at Barclays
TipRanks · 2d ago
Weekly Report: what happened at WST last week (0406-0410)?
Weekly Report · 3d ago
West to Host First-Quarter 2026 Conference Call
PR Newswire · 04/09 10:00
Notable Monday Option Activity: WST, SIRI, MRVL
NASDAQ · 04/06 19:32
Weekly Report: what happened at WST last week (0330-0403)?
Weekly Report · 04/06 09:06
Dublin Automation Expansion Could Be A Game Changer For West Pharmaceutical Services' Contract Platform (WST)
Simply Wall St · 04/05 08:19
A Look At West Pharmaceutical Services (WST) Valuation After New Dublin Expansion For Injectable Treatments
Simply Wall St · 04/03 02:38
WST Makes Bullish Cross Above Critical Moving Average
NASDAQ · 04/01 20:21
The Old Market Playbook Is Breaking - This Is The Strategy I'm Betting On
Seeking Alpha · 04/01 11:30
West Pharmaceutical expands Damastown, Dublin facility
TipRanks · 03/31 15:50
West Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity
PR Newswire · 03/31 15:46
Weekly Report: what happened at WST last week (0323-0327)?
Weekly Report · 03/30 09:06
Notable healthcare headlines for the week: Merck, Medtronic, and Novartis in focus
Seeking Alpha · 03/29 13:05
Is West Pharmaceutical Services (WST) Pricing Justified After Mixed Returns And Rich P/E Multiple
Simply Wall St · 03/27 19:07
More
Webull provides a variety of real-time WST stock news. You can receive the latest news about West Pharm Svcs through multiple platforms. This information may help you make smarter investment decisions.
About WST
West Pharmaceutical Services, Inc. is a global manufacturer that is engaged in the design and production of technologically advanced, integrated containment and delivery systems for injectable drugs and healthcare products. The Company operates in two segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers elastomers & primary containment, drug delivery devices, integrated solutions, and analytical lab services, primarily to biologic, generic, and pharmaceutical drug customers. The Contract-Manufactured Products reportable segment serves as a fully integrated business, focused on the design, manufacture, and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. This segment manufactures customer-owned components and devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.